(JJEJ) JPMorgan s (Ireland) ICAV - Ratings and Ratios

Exchange: SW • Country: Switzerland • Currency: JPY • Type: Etf • ISIN: IE0001A541Y3

JJEJ: ESG, Japanese, Equities, Large-Cap, ETF

The JPMorgan ETFs (Ireland) ICAV - Japan Research Enhanced Index Equity (ESG) UCITS ETF JPY (acc) is an exchange-traded fund that tracks the Morningstar Japan TME NR JPY index, providing investors with exposure to large-cap Japanese equities with a blend investment style.

This ETF is designed to deliver enhanced returns through a research-driven approach while incorporating Environmental, Social, and Governance (ESG) considerations. By tracking the Morningstar Japan TME NR JPY index, the fund provides broad coverage of the Japanese equity market, focusing on companies that meet specific ESG criteria.

Analyzing the funds technical data, we observe that the last price is 4453.50 JPY, indicating a recent upward trend as it is above its SMA20, SMA50, and SMA200. The Average True Range (ATR) stands at 73.23, or 1.64% of the last price, suggesting moderate volatility. Given the current price is near the upper end of its 52-week range (between 3504.00 and 4725.00), we can anticipate potential resistance around the 52-week high.

With Assets Under Management (AUM) standing at 15,413 million JPY, the fund demonstrates significant investor interest and liquidity. This substantial AUM can contribute to tighter bid-ask spreads and lower trading costs for investors.

Forecasting future performance using both technical and fundamental data, we can hypothesize that if the current upward trend continues and the fund maintains its position above key moving averages, it may challenge its 52-week high. However, the incorporation of ESG factors and the overall market sentiment towards Japanese equities will play crucial roles in determining its trajectory. A break above the 52-week high could signal further potential upside, while failure to do so might result in consolidation or a pullback.

Investors should closely monitor the funds price action relative to its moving averages and the overall market conditions. The decision to invest should be based on a thorough analysis of the investors risk tolerance, investment goals, and the funds alignment with these objectives.

Additional Sources for JJEJ ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

JJEJ ETF Overview

Market Cap in USD 106m
Category Japan Large-Cap Blend Equity
IPO / Inception 2022-10-07

JJEJ ETF Ratings

Growth Rating 37.3
Fundamental -
Dividend Rating 0.0
Rel. Strength -9.21
Analysts -
Fair Price Momentum 3968.73 JPY
Fair Price DCF -

JJEJ Dividends

Currently no dividends paid

JJEJ Growth Ratios

Growth Correlation 3m -12.1%
Growth Correlation 12m 27.9%
Growth Correlation 5y 33.6%
CAGR 5y 25.13%
CAGR/Max DD 5y 1.18
Sharpe Ratio 12m 0.83
Alpha 10.86
Beta 0.932
Volatility 24.02%
Current Volume 0.1k
Average Volume 20d 1.3k
What is the price of JJEJ shares?
As of June 16, 2025, the stock is trading at JPY 4448.50 with a total of 144 shares traded.
Over the past week, the price has changed by -0.59%, over one month by +1.02%, over three months by +1.27% and over the past year by +3.53%.
Is JPMorgan s (Ireland) ICAV a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, JPMorgan s (Ireland) ICAV (SW:JJEJ) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 37.32 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of JJEJ is around 3968.73 JPY . This means that JJEJ is currently overvalued and has a potential downside of -10.78%.
Is JJEJ a buy, sell or hold?
JPMorgan s (Ireland) ICAV has no consensus analysts rating.
What are the forecasts for JJEJ share price target?
According to our own proprietary Forecast Model, JJEJ JPMorgan s (Ireland) ICAV will be worth about 4518.8 in June 2026. The stock is currently trading at 4448.50. This means that the stock has a potential upside of +1.58%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 4518.8 1.6%